265 related articles for article (PubMed ID: 20619530)
1. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.
Kaag MG; O'Malley RL; O'Malley P; Godoy G; Chen M; Smaldone MC; Hrebinko RL; Raman JD; Bochner B; Dalbagni G; Stifelman MD; Taneja SS; Huang WC
Eur Urol; 2010 Oct; 58(4):581-7. PubMed ID: 20619530
[TBL] [Abstract][Full Text] [Related]
2. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
[TBL] [Abstract][Full Text] [Related]
3. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.
Lane BR; Smith AK; Larson BT; Gong MC; Campbell SC; Raghavan D; Dreicer R; Hansel DE; Stephenson AJ
Cancer; 2010 Jun; 116(12):2967-73. PubMed ID: 20564402
[TBL] [Abstract][Full Text] [Related]
5. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
[TBL] [Abstract][Full Text] [Related]
6. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
[TBL] [Abstract][Full Text] [Related]
7. Comparing Changes in Renal Function After Radical Surgery for Upper Tract Urothelial Carcinoma and Renal Cell Carcinoma.
Singla N; Hutchinson R; Menegaz C; Haddad AQ; Jiang L; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
Urology; 2016 Oct; 96():44-53. PubMed ID: 27443467
[TBL] [Abstract][Full Text] [Related]
8. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
[TBL] [Abstract][Full Text] [Related]
9. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy.
Rajput MZ; Kamat AM; Clavell-Hernandez J; Siefker-Radtke AO; Grossman HB; Dinney CP; Matin SF
Urology; 2011 Jul; 78(1):61-7. PubMed ID: 21354598
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L
Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
[TBL] [Abstract][Full Text] [Related]
12. Segmental ureterectomy vs. radical nephroureterectomy for ureteral carcinoma in patients with a preoperative glomerular filtration rate less than 90 ml/min/1.73 m
Abrate A; Sessa F; Campi R; Preto M; Olivero A; Varca V; Benelli A; Sessa M; Sebastianelli A; Pavone C; Serretta V; Vella M; Brunocilla E; Serni S; Trombetta C; Terrone C; Gregori A; Lissiani A; Gontero P; Schiavina R; Gacci M; Simonato A
Urol Oncol; 2020 Jun; 38(6):601.e11-601.e16. PubMed ID: 32273050
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma.
Singla N; Hutchinson R; Haddad A; Sagalowsky A; Lotan Y; Margulis V
Can J Urol; 2016 Aug; 23(4):8334-41. PubMed ID: 27544555
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
15. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
[TBL] [Abstract][Full Text] [Related]
16. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy.
Shao IH; Lin YH; Hou CP; Juang HH; Chen CL; Chang PL; Tsui KH
Drug Des Devel Ther; 2014; 8():1985-90. PubMed ID: 25364228
[TBL] [Abstract][Full Text] [Related]
18. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury strongly influences renal function after radical nephroureterectomy for upper tract urothelial carcinoma: A single-centre experience.
Tafuri A; Odorizzi K; Di Filippo G; Cerrato C; Fassio G; Serafin E; Princiotta A; D'Aietti D; Gozzo A; Porcaro AB; Brunelli M; Cerruto MA; Antonelli A
Arch Ital Urol Androl; 2021 Mar; 93(1):9-14. PubMed ID: 33754601
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
